253 results on '"Muñoz-Fontela, César"'
Search Results
2. Vaccines and Antiviral Developments for SARS-CoV-2 in the Emergence of the COVID-19 Pandemic
3. Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study
4. Correction to 'Long-term wildlife mortality surveillance in northern Congo : a model for the detection of Ebola virus disease epizootics'
5. Long-term wildlife mortality surveillance in northern Congo : a model for the detection of Ebola virus disease epizootics
6. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
7. Development and validation of portable, field-deployable Ebola virus point-of-encounter diagnostic assay for wildlife surveillance
8. Animal models for COVID-19
9. T-Cell Receptor Diversity and the Control of T-Cell Homeostasis Mark Ebola Virus Disease Survival in Humans
10. Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease
11. Ebola Virus Disease in Humans: Pathophysiology and Immunity
12. Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection
13. Humanized Mice Reproduce Acute and Persistent Human Adenovirus Infection
14. N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile
15. Data from Expression of the p53 Target CDIP Correlates with Sensitivity to TNFα-Induced Apoptosis in Cancer Cells
16. Supplementary Methods, Table 1, Figures 1-6 from Expression of the p53 Target CDIP Correlates with Sensitivity to TNFα-Induced Apoptosis in Cancer Cells
17. Ebola Virus Disease Is Characterized by Poor Activation and Reduced Levels of Circulating CD16⁺ Monocytes
18. Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses
19. Animal Model Alternatives in Filovirus and Bornavirus Research
20. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation
21. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
22. An introduction to the Marburg virus vaccine consortium, MARVAC
23. Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
24. Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors
25. Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
26. Emerging roles of p53 and other tumour-suppressor genes in immune regulation
27. A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
28. Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during the 2018 outbreak reveals presence of seropositive bats
29. Inactivation Methods for Experimental Nipah Virus Infection
30. Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase
31. Unique human immune signature of Ebola virus disease in Guinea
32. Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
33. Working group 'Clinical management and epidemiology of emerging infections' : Schlussbericht zum DZIF-Vorhaben
34. Advances and gaps in SARS-CoV-2 infection models
35. Quantification of Type I Interferon Inhibition by Viral Proteins: Ebola Virus as a Case Study
36. Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype
37. SARS-CoV-2 Variants and Vaccines
38. Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition
39. Metagenomic Snapshots of Viral Components in Guinean Bats
40. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
41. Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
42. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues
43. Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
44. An inability to maintain the ribonucleoprotein genomic structure is responsible for host detection of negative-sense RNA viruses
45. Regulation of the Ebola Virus VP24 Protein by SUMO
46. Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice
47. Monocyte‐derived dendritic cells enhance protection against secondary influenza challenge by controlling the switch in CD8+ T‐cell immunodominance
48. 292 p53 Transcriptionally activates IRF9 to enhance antiviral immunity
49. S3_Diagnostic method from Long-term wildlife mortality surveillance in Northern Congo: a model for the detection of Ebola virus disease epizootics
50. S1_Posters from Long-term wildlife mortality surveillance in Northern Congo: a model for the detection of Ebola virus disease epizootics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.